Small-molecule agents for cancer immunotherapy

• Main Authors: Fang Wang (Author), Kai Fu (Author), Yujue Wang (Author), Can Pan (Author), Xueping Wang (Author), Zeyu Liu (Author), Chuan Yang (Author), Ying Zheng (Author), Xiaopeng Li (Author), Yu Lu (Author), Kenneth Kin Wah To (Author), Chenglai Xia (Author), Jianye Zhang (Author), Zhi Shi (Author), Zeping Hu (Author), Min Huang (Author), Liwu Fu (Author)
• Format: Book
• Published: Elsevier, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Cancer immunotherapy, exemplified by the remarkable clinical benefits of the immune checkpoint blockade and chimeric antigen receptor T-cell therapy, is revolutionizing cancer therapy. They induce long-term tumor regression and overall survival benefit in many types of cancer. With the advances in o...